Talon Compounding Pharmacy Injectable Drug Recalled for Sterility Assurance
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling an injectable combination drug (Lot T1008312021:33) due to lack of assurance of sterility. The affected product was distributed across the United States, including Washington, D.C. and Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a sterility defect in an injectable drug product. Injectable products with compromised sterility assurance pose significant risk of serious infection or harm; this classification meets the Severe threshold for Class II recalls with potential for serious injury.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling an injectable combination product containing Test Cypionate 200mg, Anastrozole 0.75mg, and Dutasteride 1mg/mL in oil. The recall was initiated due to lack of assurance of sterility.
The recalled product is a 2-vial injectable, prescription-only medication (Lot T1008312021:33, BUD 02/27/2022) manufactured by Vita Pharmacy, LLC dba Talon Compounding Pharmacy, located at 2950 Thousand Oaks Drive, Suite 25, San Antonio, Texas 78247.
The product was distributed across the United States, including Washington, D.C. and Puerto Rico. Patients who have received this product should consult their healthcare provider immediately. Healthcare providers should discontinue use of this lot and contact the pharmacy for guidance on appropriate actions.
The recalled product
- Product
- TEST CYPIONATE 200MG/ANASTROZOLE 0.75MG/DUTASTERIDE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Hazard
- sterility-assurance
- injectable-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: T1008312021:33 BUD: 02/27/2022
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27